Irnocam 100mg Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Irnocam 100mg Injection contains irinotecan, a topoisomerase-inhibitor cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of advanced or metastatic colorectal cancer — cancers of the colon or rectum — and it is also prescribed to manage disease that has recurred or progressed after a chemotherapy session with 5-Fluorouracil. It is described as blocking the action of the enzymes responsible for the growth and multiplication of cancer cells. It can be prescribed together with other anticancer medicines for better results, and is given only by a qualified doctor or nurse.
Product Information
The following description reflects information associated with irinotecan and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for managing advanced or metastatic cancers of the colon or rectum
- Described for managing disease that has recurred or progressed after chemotherapy with 5-Fluorouracil
- Described as blocking the enzymes responsible for the growth and multiplication of cancer cells; may be prescribed with other anticancer medicines
Described Dosage & Administration
- Given only by a professional doctor or nurse, with the utmost care and at the right place
- May be prescribed together with other anticancer medicines for better results
- The dose and schedule are set by the treating doctor
Described Side Effects
Commonly described side effects include:
- Anaemia, pale skin, and tiredness
- Increased infections
- Loss of appetite
- Hair loss
- Nausea and stomach pain
- Mouth ulcers
- Weakness
- Increased bleeding tendency due to low blood platelet counts
- Difficulty passing stools
These are described as commonly temporary. The doctor should be consulted if they persist, and any severe reaction requires prompt medical attention.
Precautions
- A complete medical history should be shared with the healthcare team
- Any heart or kidney issues or hypertension should be reported specifically
- It is described as not for pregnant or breastfeeding women
- It may be prescribed with other anticancer medicines for better results
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains irinotecan and is used for the treatment of advanced or metastatic colorectal cancer, including disease that has recurred or progressed after chemotherapy with 5-Fluorouracil. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as given only by a professional doctor or nurse. It may be prescribed together with other anticancer medicines for better results.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.